ID: ALA316806

Max Phase: Preclinical

Molecular Formula: C15H15NO2

Molecular Weight: 241.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C)c1cccc(-c2ccc(C(=O)O)cc2)c1

Standard InChI:  InChI=1S/C15H15NO2/c1-16(2)14-5-3-4-13(10-14)11-6-8-12(9-7-11)15(17)18/h3-10H,1-2H3,(H,17,18)

Standard InChI Key:  UJFZKWPBNXPXRR-UHFFFAOYSA-N

Associated Targets(non-human)

Human papillomavirus regulatory protein E2 38 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 241.29Molecular Weight (Monoisotopic): 241.1103AlogP: 3.12#Rotatable Bonds: 3
Polar Surface Area: 40.54Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.99CX Basic pKa: 5.24CX LogP: 2.02CX LogD: 0.28
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.90Np Likeness Score: -0.69

References

1. Hajduk PJ, Dinges J, Miknis GF, Merlock M, Middleton T, Kempf DJ, Egan DA, Walter KA, Robins TS, Shuker SB, Holzman TF, Fesik SW..  (1997)  NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein.,  40  (20): [PMID:9379433] [10.1021/jm9703404]

Source